Jim Cramer's Latest Post

Miracle Drug May Be Ailin...

More Trading Strategies

By

Jim Collins

 | Apr 23, 2014 | 5:00 PM EDT |
Don't look to the past, look to earnings estimates of the future.
By

James "Rev Shark" DePorre

 | Apr 23, 2014 | 4:41 PM EDT |
A poor reaction will present a major hurdle to further upside.
By

Roger Arnold

 | Apr 23, 2014 | 4:00 PM EDT |
I wouldn't be so quick to jump on the bubble-bursting bandwagon.
By

Jim Cramer

 | Apr 23, 2014 | 3:48 PM EDT |
Its potent hepatitis C treatment is not a boon for shareholders.
By

Christopher Versace

 | Apr 23, 2014 | 3:00 PM EDT |
Let's put some of these numbers in perspective.
By

Tim Melvin

 | Apr 23, 2014 | 2:00 PM EDT |
This is probably the least important number in all of finance.
By

Jim Cramer

 | Apr 23, 2014 | 1:38 PM EDT |
Let's tick down what hasn't gone wrong -- and what's making this market so resilient.
By

Sham Gad

 | Apr 23, 2014 | 1:00 PM EDT |
During bull markets, it's even more important to avoid portfolio damage.
By

Timothy Collins

 | Apr 23, 2014 | 12:12 PM EDT |
It is knowing that there is no key.
By

Gary Dvorchak

 | Apr 23, 2014 | 12:00 PM EDT |
Generally speaking, I would never be long any name appearing on this list.
By

Mike Norman

 | Apr 23, 2014 | 12:00 PM EDT |
The move is still out of bonds and into stocks.
By

Eric Jackson

 | Apr 23, 2014 | 11:30 AM EDT |
Reports indicate the Chinese Internet giant could file next week.
By

Kate Stalter

 | Apr 23, 2014 | 11:00 AM EDT |
Many people would rather be right than rich.
By

Dan Fitzpatrick

 | Apr 23, 2014 | 10:20 AM EDT |
Run from those who tout themsleves as 'gurus' and don't look back.
By

Brian Sozzi

 | Apr 23, 2014 | 10:00 AM EDT |
Here are the key macro takeaways in this report.

Upgrades & Downgrades

Bullish
Apr 23, 2014 | 8:31 AM EDT
Shares of UTX now seen reaching $135, according to Credit Suisse. Estimates also upped, given a higher growth outlook. Outperform ratin…
Bullish
Apr 23, 2014 | 8:29 AM EDT
EFX was upgraded from Neutral to Outperform, Credit Suisse said. $80 price target. Organic revenue growth should accelerate. 
Apr 23, 2014 | 8:26 AM EDT
Shares of CREE now seen reaching $65, according to Sterne Agee. Estimates also reduced, as the company is realizing lower lighting marg…
Apr 23, 2014 | 8:25 AM EDT
Shares of ISRG now seen reaching $360, according to Sterne Agee. Estimates also cut, given weak procedure growth. Underperform rating.&…
Bullish
Apr 23, 2014 | 8:24 AM EDT
GSK was upgraded from Hold to Buy, Argus said. Asset swap with Novartis is attractive. 
Apple was off $6.95 (1.31%) in regular trading but is up over $37 (~7%) in the after marke...
You're likely aware of next week's Fed meeting, but we want to remind you that the equity ...
Market finally pulling back a bit after six straight days of gains. Small caps are behavi...
Cramer:  
IBM
IBM is an action alerts plus.com name and I think that it represents great value versus wh...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.